Santos Revenu Y/Y
Quel est le Revenu Y/Y de Santos?
Le Revenu Y/Y de Santos Ltd. est 71.30%
Quelle est la définition de Revenu Y/Y?
La croissance annuelle des revenus des trois dernières années correspond à la croissance moyenne des revenus d’une année sur l’autre au cours des trois dernières années.
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenu Y/Y des entreprises dans Energy secteur sur OTC par rapport à Santos
Que fait Santos?
Santos Limited explores for, develops, produces, transports, and markets hydrocarbons for homes and businesses in Australia and the Asia Pacific. Its five principal assets are located in the Cooper Basin, Queensland and NSW, Papua New Guinea, Northern Australia and Timor-Leste, and Western Australia. The company also holds an asset in Alaska; and engages in the development of carbon capture and storage technologies. In addition, it produces natural gas, liquefied petroleum gas, ethane, methane, coal seam gas, liquefied natural gas, shale gas, and condensate, as well as oil. The company's proved plus probable reserves include 1676 million barrels of oil equivalent. Santos Limited was incorporated in 1954 and is headquartered in Adelaide, Australia.
Entreprises avec revenu y/y similaire à Santos
- BeiGene a Revenu Y/Y de 71.00%
- BeiGene Ltd a Revenu Y/Y de 71.01%
- Satia Industries a Revenu Y/Y de 71.02%
- Aegis Logistics a Revenu Y/Y de 71.05%
- abrdn Australia Equity Fund Inc a Revenu Y/Y de 71.05%
- Rushil Decor a Revenu Y/Y de 71.09%
- Santos a Revenu Y/Y de 71.30%
- Honda Siel Power Products a Revenu Y/Y de 71.31%
- Cairn Homes plc a Revenu Y/Y de 71.36%
- Kymera Therapeutics a Revenu Y/Y de 71.38%
- Stoke Therapeutics a Revenu Y/Y de 71.38%
- First Citizens BancShares a Revenu Y/Y de 71.48%
- Sanara MedTech a Revenu Y/Y de 71.51%